INVO Fertility to Present at H.C. Wainwright Conference, Highlighting Expansion Strategy
Event summary
- INVO Fertility to participate in H.C. Wainwright's 28th Annual Global Investment Conference from September 14-16, 2026.
- Pre-recorded presentation available from September 11, 2026, at 7:00 a.m. ET.
- Management team to hold one-on-one investor meetings during the conference.
- Company operates four fertility clinics in the U.S. and sells INVOcell technology to third-party clinics.
The big picture
INVO Fertility's participation in the H.C. Wainwright conference underscores its focus on expanding access to assisted reproductive technology. The company's dual strategy of clinic acquisitions and technology sales positions it within the broader trend of consolidating fertility services. With four operational clinics and a proprietary device, INVO Fertility aims to capitalize on the growing demand for ART care.
What we're watching
- Expansion Strategy
- How INVO Fertility's acquisition of U.S.-based, profitable fertility clinics will impact its market position.
- Technology Adoption
- The pace at which third-party clinics adopt INVOcell technology and its revenue contribution.
- Investor Sentiment
- Whether the conference presentations will shift investor perception of INVO Fertility's growth prospects.